The associations between CYP24A1 polymorphisms and cancer susceptibility: A meta-analysis and trial sequential analysis.
作者： Man Zhu , Shili Qiu , Xianwei Zhang , Yingchao Wang , Tapara D.M. Souraka
DOI: 10.1016/J.PRP.2017.11.014
关键词: Meta-analysis 、 Breast cancer 、 Vitamin D and neurology 、 Confidence interval 、 Internal medicine 、 Odds ratio 、 Oncology 、 Cancer development 、 Medicine 、 Cancer susceptibility 、 CYP24A1
摘要: … the risk of pancreas cancer, while … cancer expressed higher levels of CYP24A1 than normal tissues. Therefore, we believe that CYP24A1 may possess potential clinical value in cancer. …
sci-hub.se 参考文章(37)
Annika Schäfer, Steffen Emmert, Jochen Kruppa, Steffen Schubert, Mladen Tzvetkov, Rotraut Mössner, Kristian Reich, Carola Berking, Matthias Volkenandt, Claudia Pföhler, Michael P. Schön, Thomas Vogt, Inke R. König, Jörg Reichrath, No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study. Archives of Dermatological Research. ,vol. 304, pp. 353- 361 ,(2012) , 10.1007/S00403-012-1243-3
Crystal N. Holick, Janet L. Stanford, Erika M. Kwon, Elaine A. Ostrander, Sergey Nejentsev, Ulrike Peters, Comprehensive Association Analysis of the Vitamin D Pathway Genes, VDR, CYP27B1, and CYP24A1, in Prostate Cancer Cancer Epidemiology, Biomarkers & Prevention. ,vol. 16, pp. 1990- 1999 ,(2007) , 10.1158/1055-9965.EPI-07-0487
Song Yao, Gary Zirpoli, Dana H Bovbjerg, Lina Jandorf, Chi Chen Hong, Hua Zhao, Lara E Sucheston, Li Tang, Michelle Roberts, Gregory Ciupak, Warren Davis, Helena Hwang, Candace S Johnson, Donald L Trump, Susan E McCann, Foluso Ademuyiwa, Karen S Pawlish, Elisa V Bandera, Christine B Ambrosone, Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Research. ,vol. 14, pp. 1- 13 ,(2012) , 10.1186/BCR3162
David Feldman, Aruna V. Krishnan, Srilatha Swami, Edward Giovannucci, Brian J. Feldman, The role of vitamin D in reducing cancer risk and progression Nature Reviews Cancer. ,vol. 14, pp. 342- 357 ,(2014) , 10.1038/NRC3691
D O'Leary, Z Al Maskari, PB.15: Pain in mammography: where and why does it arise? Breast Cancer Research. ,vol. 15, pp. 15- ,(2013) , 10.1186/BCR3515
Jun Wang, A. Heather Eliassen, Donna Spiegelman, Walter C. Willett, Susan E. Hankinson, Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses’ Health Study II Cancer Causes & Control. ,vol. 25, pp. 819- 827 ,(2014) , 10.1007/S10552-014-0383-5
Sarah K. Holt, Erika M. Kwon, Ulrike Peters, Elaine A. Ostrander, Janet L. Stanford, Vitamin D Pathway Gene Variants and Prostate Cancer Risk Cancer Epidemiology, Biomarkers & Prevention. ,vol. 18, pp. 1929- 1933 ,(2009) , 10.1158/1055-9965.EPI-09-0113
Laura N. Anderson, Michelle Cotterchio, Julia A. Knight, Ayelet Borgida, Steven Gallinger, Sean P. Cleary, Genetic Variants in Vitamin D Pathway Genes and Risk of Pancreas Cancer; Results from a Population-Based Case-Control Study in Ontario, Canada PLoS ONE. ,vol. 8, pp. e66768- ,(2013) , 10.1371/JOURNAL.PONE.0066768
Lyman W Whitlatch, Michael V Young, Gary G Schwartz, John N Flanagan, Kerry L Burnstein, Bal L Lokeshwar, Edwin S Rich, Michael F Holick, Tai C Chen, 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 81, pp. 135- 140 ,(2002) , 10.1016/S0960-0760(02)00053-5
Yeonju Kim, Adrian A Franke, Yurii B Shvetsov, Lynne R Wilkens, Robert V Cooney, Galina Lurie, Gertraud Maskarinec, Brenda Y Hernandez, Loïc Le Marchand, Brian E Henderson, Laurence N Kolonel, Marc T Goodman, Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case–control study in the multiethnic cohort study BMC Cancer. ,vol. 14, pp. 29- 29 ,(2014) , 10.1186/1471-2407-14-29